We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$3.24B
(+24%)
Cap. Flow
+$4.87B
Cap. Flow
% of AUM
28.99%
Top 10 Holdings %
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$169M |
| 2 |
Coca-Cola
KO
|
+$155M |
| 3 |
McDonald's
MCD
|
+$140M |
| 4 |
Mondelez International
MDLZ
|
+$127M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$174M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$133M |
| 3 |
Workday
WDAY
|
+$110M |
| 4 |
Johnson & Johnson
JNJ
|
+$98.4M |
| 5 |
ConocoPhillips
COP
|
+$93.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 11.8% |
| 3 | Healthcare | 10.7% |
| 4 | Industrials | 9.22% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
iShares Russell 3000 ETF
IWV
$19.3B
| $150K | ﹤0.01% |
723
+655
| +963% | +$151K |
|
1852
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$518M
| $150K | ﹤0.01% |
+1,068
| New | +$196K |
|
1853
Latham Group
SWIM
$646M
| $150K | ﹤0.01% |
+41,662
| New | +$238K |
|
1854
ProShares UltraPro S&P 500
UPRO
$5B
| $150K | ﹤0.01% |
5,293
-1,230
| -19% | -$49.3K |
|
1855
iShares MSCI USA Value Factor ETF
VLUE
$9.2B
| $149K | ﹤0.01% |
+1,819
| New | +$169K |
|
1856
Vanguard Large-Cap ETF
VV
$51.6B
| $149K | ﹤0.01% |
909
+842
| +1,257% | +$153K |
|
1857
Voyager Therapeutics
VYGR
$187M
| $149K | ﹤0.01% |
25,163
+6,544
| +35% | +$41.9K |
|
1858
Fidelity MSCI Communication Services Index ETF
FCOM
$1.8B
| $148K | ﹤0.01% |
4,733
-1,449
| -23% | -$52.3K |
|
1859
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$262M
| $148K | ﹤0.01% |
4,134
+1,925
| +87% | +$79.5K |
|
|
RPTX
1860
DELISTED
Repare Therapeutics
RPTX
| $148K | ﹤0.01% |
12,233
-3,596
| -23% | -$46.3K |
|
1861
Accuray
ARAY
$28.2M
| $147K | ﹤0.01% |
70,596
-30,307
| -30% | -$68.9K |
|
1862
VanEck Biotech ETF
BBH
$409M
| $147K | ﹤0.01% |
1,046
+805
| +334% | +$122K |
|
1863
Biomea Fusion
BMEA
$89.7M
| $147K | ﹤0.01% |
+14,996
| New | +$172K |
|
|
BRY
1864
DELISTED
Berry Corp
BRY
| $147K | ﹤0.01% |
19,642
-167,264
| -89% | -$1.41M |
|
1865
Apyx Medical
APYX
$156M
| $146K | ﹤0.01% |
32,418
+5,643
| +21% | +$40.4K |
|
|
UNIT
1866
Uniti Group
UNIT
$2.48B
| $146K | ﹤0.01% |
21,007
-93,859
| -82% | -$872K |
|
1867
Global X Cybersecurity ETF
BUG
$1.25B
| $145K | ﹤0.01% |
+6,032
| New | +$159K |
|
1868
GeoPark
GPRK
$612M
| $145K | ﹤0.01% |
12,340
-3,933
| -24% | -$48.3K |
|
1869
iShares North American Natural Resources ETF
IGE
$732M
| $145K | ﹤0.01% |
4,158
-29,041
| -87% | -$1.08M |
|
1870
Omeros
OMER
$834M
| $145K | ﹤0.01% |
45,913
+4,918
| +12% | +$22.8K |
|
|
WSR
1871
DELISTED
Whitestone REIT
WSR
| $143K | ﹤0.01% |
16,907
-4,476
| -21% | -$45.9K |
|
1872
WisdomTree US Total Dividend Fund
DTD
$1.65B
| $141K | ﹤0.01% |
2,595
+2,096
| +420% | +$125K |
|
1873
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
| $141K | ﹤0.01% |
+3,039
| New | +$148K |
|
1874
OP Bancorp
OPBK
$238M
| $140K | ﹤0.01% |
12,569
+2,066
| +20% | +$23.7K |
|
1875
Spok Holdings
SPOK
$229M
| $140K | ﹤0.01% |
18,368
+3,342
| +22% | +$23.2K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review
As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
- Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
- Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.